8-K 1 fresen_8k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------------------------ FORM 8-K CURRENT REPORT Pursuant to Sections 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2002 ----------------- FRESENIUS MEDICAL CARE HOLDINGS, INC. ----------------------------------------------------- (Exact name of registrant as specified in its charter) New York --------------------------------------------- (State or other jurisdiction of incorporation) 1-3720 13-3461988 -------------------------------------------------------------------------------- (Commission File Number (IRS Employer Identification No.) 95 Hayden Avenue Lexington, Massachusetts 02420 -------------------------------------------------------------------------------- (Address or principal executive offices) (Zip Code) Registrant's telephone number, including area codes: (781) 402-9000 -------------- Not Applicable -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) ITEM 5. Other Events On February 13, 2002, Fresenius Medical Care AG, the parent corporation of Fresenius Medical Care Holdings, Inc., announced a special charge to be taken in the fourth quarter of 2001. A copy of Fresenius Medical Care AG's Investor News release is attached as an exhibit to this report. ITEM 7. Financial Statements and Exhibits Exhibit 99 Investor News release dated February 13, 2002 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. FRESENIUS MEDICAL CARE HOLDINGS, INC. /s/ BEN J. LIPPS ------------------------------------------ DATE: February 13, 2002 Name: Ben J. Lipps Title: Chief Executive Officer 2